REAL-WORLD HEALTHCARE RESOURCE UTILIZATION IN URTICARIA PATIENTS NEWLY TREATED WITH OMALIZUMAB IN THE UNITED STATES

被引：0

作者：

Ke, X. ^{[1
]}

Kavati, A. ^{[2
]}

Wertz, D. ^{[1
]}

Huang, Q. ^{[1
]}

Wang, L. ^{[1
]}

Willey, V. J. ^{[1
]}

Stephenson, J. J. ^{[1
]}

Ortiz, B. ^{[2
]}

Paknis, B. ^{[2
]}

Bernstein, J. A. ^{[3
]}

Beck, L. A. ^{[4
]}

机构：

[1] HealthCore Inc, Wilmington, DE USA

[2] Novartis Pharmaceut, E Hanover, NJ USA

[3] Bernstein Clin Res Ctr LLC, Cincinnati, OH USA

[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA

来源：

VALUE IN HEALTH | 2017年 / 20卷 / 05期

关键词：

D O I：

暂无

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PSS32

引用

页码：A161 / A161

页数：1

共 50 条

[1] Real-World Healthcare Resource Utilization in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the United States
Laliberte, Francois
Raut, Monika
Yang, Xiaoqin
Germain, Guillaume
Sen, Shuvayu S.
MacKnight, Sean D.
Desai, Kaushal D.
Duh, Mei Sheng
[J]. BLOOD, 2019, 134
[2] OMALIZUMAB USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: A REAL-WORLD SURVEY IN THE UNITED STATES
Holden, M.
Seetasith, A.
Hetherington, J.
Wrest, E.
Keal, A.
Salmon, P.
Mosnaim, G.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S41 - S41
[3] Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States
Eghrari-Sabet, Jacqueline
Sher, Ellen
Kavati, Abhishek
Pilon, Dominic
Zhdanava, Maryia
Balp, Maria-Magdalena
Lefebvre, Patrick
Ortiz, Benjamin
Bernstein, Jonathan A.
[J]. ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) : 191 - 200
[4] REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS IN URTICARIA PATIENTS INITIATING OMALIZUMAB IN THE UNITED STATES
Wang, L.
Kavati, A.
Ke, X.
Wertz, D.
Huang, Q.
Willey, V.
Stephenson, J.
Ortiz, B.
Bernstein, B. Paknis J.
Beck, L.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S44 - S44
[5] Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
Ke, Xuehua
Kavati, Abhishek
Wertz, Debra
Huang, Qing
Wang, Liya
Willey, Vincent J.
Stephenson, Judith J.
Ortiz, Benjamin
Paknis, Brandee
Bernstein, Jonathan A.
Beck, Lisa A.
[J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 598 - +
[6] REAL-WORLD EFFECTIVENESS OF OMALIZUMAB IN PATIENTS TREATED FOR CHRONIC SPONTANEOUS URTICARIA
Garmo, V.
Seetasith, A.
Holden, M.
Broder, M.
Chang, E.
Tarbox, M.
Mosnaim, G.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S33 - S33
[7] Real-world healthcare resource utilization and costs among patients with multiple myeloma in the United States.
Gupta, Niodita
Tai, Ming-Hui
Kaila, Shuchita
Thompson-Leduc, Philippe
Ghelerter, Isabelle
Kurteva, Siyana
Lefebvre, Patrick
Lafeuille, Marie-Helene
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18811 - E18811
[8] A REAL-WORLD ASSESSMENT OF OMALIZUMAB TREATMENT PATTERNS IN ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB
Ke, X.
Kavati, A.
Wertz, D.
Huang, Q.
Wang, L.
Willey, V.
Stephenson, J.
Ortiz, B.
Panettieri, R., Jr.
Corren, J.
[J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S53 - S53
[9] A REAL WORLD PROFILE OF THE BASELINE CHARACTERISTICS OF ASTHMA PATIENTS NEWLY TREATED WITH OMALIZUMAB IN THE UNITED STATES
Ke, X.
Kavati, A.
Wertz, D.
Huang, Q.
Wang, L.
Willey, V. J.
Stephenson, J. J.
Ortiz, B.
Panettieri, Jr R. A.
Corren, J.
[J]. VALUE IN HEALTH, 2017, 20 (05) : A207 - A207
[10] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
Tepper, S. J.
Schwedt, T. J.
Vo, P.
Joshi, P.
Glassberg, M.
Abdrabboh, A.
Ferraris, M.
Tiwari, S.
Thompson, J.
[J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 26 - 26

← 1 2 3 4 5 →